0 - 50 empleados
LeadArtis is an early stage biotechnology company based in Madrid (Spain) that develops targeted drugs based on its proprietary Trimerbody® protein engineering platform. Trimerbody® is an alternative antibody format that employs specific trimerization domains and optimized peptide connectors to provide advantages over conventional antibodies including simultaneous multivalent / multispecific targeting (up to six per molecule), reduced size, higher avidity for targets, and a variety of effector possibilities, receptor modulation, soluble factor neutralization, payload delivery etc. Our key therapeutic area for pipeline development is oncology. Additionally, we offer our Trimerbody® platform to partners interested in developing targeted drugs benefiting from the Trimerbody® format.
Sector: Salud / Medicina
